The presence of unlisted compounds creates significant medical risks. True psilocybin mushrooms carry a well-documented physiological safety profile, but synthetic analogues and unmeasured tryptamine cocktails introduce dangerous physiological variables. When users do not know the exact chemical structure or dosage they are consuming, adverse side effects rise sharply.
Poison control centers and emergency physicians have treated patients suffering from tachycardia, severe hypotension, seizures, and acute psychosis following consumption of over-the-counter mushroom treats. The risk multiplies when consumers combine these products with prescription medications. Selective serotonin reuptake inhibitors (SSRIs), when taken alongside undisclosed synthetic tryptamines or MAOIs added to enhance the high, can trigger serotonin syndrome, a potentially fatal medical condition.
Beyond pharmacological toxicity, the psychological trauma of an unexpected trip remains severe. A consumer expecting mild focus from an adaptogen supplement who suddenly experiences intense ego dissolution can panic, leading to physical self-injury or long-lasting panic disorders.
